Global DNA Methylation Detection Technology Market Size To Exceed USD 16.35 Billion By 2035 | CAGR Of 15.85%
Category: HealthcareGlobal DNA Methylation Detection Technology Market Size To Exceed USD 16.35 Billion By 2035
According to a Research Report Published by Spherical Insights & Consulting, The Global DNA Methylation Detection Technology Market Size is Expected to Grow from USD 3.24 Billion in 2024 to USD 16.35 Billion by 2035, at a CAGR of 15.85% during the Forecast Period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 253 pages with 127 Market data tables and figures & charts from the report on the "Global DNA Methylation Detection Technology Market Size, Share, and COVID-19 Impact Analysis, By Technology (Polymerase Chain Reaction (PCR), Microarray, Sequencing, and Others), By Application (Translational Research and Diagnostic Procedure), By End User (Contract Research Organization (CRO), Research & Academic Laboratories, Biopharmaceutical & Biotech Companies, and Other End User), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/dna-methylation-detection-technology-market
The DNA Methylation Detection Technology Market Size is the industry of technologies and methods used for identifying and analysing DNA methylation patterns, which are epigenetic modifications that are crucial for gene expression regulation. Research & development activities emphasizing genomics and epigenetics are accelerating the advancements in DNA methylation detection methods, thereby escalating the market growth opportunities. An increasing prevalence of cancer and other chronic diseases, driving demand for DNA methylation detection technology, is propelling the market for DNA methylation detection technology. Further, the rising number of collaborations and startups for advancing DNA methylation detection technology among the biotechnology and pharmaceutical industries is promoting the market growth. However, the lack of qualified professional criteria for the safety and health of the technology is challenging the market growth.
The polymerase chain reaction (PCR) segment dominated the DNA methylation detection technology market in 2024 and is projected to grow at a rapid CAGR during the forecast period.
Based on the technology, the DNA methylation detection technology market is divided into polymerase chain reaction (PCR), microarray, sequencing, and others. Among these, the polymerase chain reaction (PCR) segment dominated the DNA methylation detection technology market in 2024 and is projected to grow at a rapid CAGR during the forecast period. The growing prevalence of infectious and genetic diseases, along with the rising need for clinical diagnostics and personalized medicine, is driving the market demand.
The diagnostic procedure segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the application, the DNA methylation detection technology market is divided into translational research and diagnostic procedure. Among these, the diagnostic procedure segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The growing emphasis on the use of DNA methylation analysis for clinical diagnostics is propelling the DNA methylation detection technology market growth.
The biopharmaceutical & biotech companies segment accounted for the largest market share in 2024 and is expected to grow at a substantial CAGR during the projected timeframe.
Based on the end user, the DNA methylation detection technology market is divided into contract research organization (CRO), research & academic laboratories, biopharmaceutical & biotech companies, and other end user. Among these, the biopharmaceutical & biotech companies segment accounted for the largest market share in 2024 and is expected to grow at a substantial CAGR during the projected timeframe. The expanding application of DNA methylation analysis for drug discovery, development, and personalized medicine applications is driving the market in the biopharmaceutical & biotech companies segment.
North America is expected to hold the majority share of the global DNA methylation detection technology market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global DNA methylation detection technology market during the forecast period. The presence of strong healthcare infrastructure, extensive R&D efforts, and a growing number of biotechnology & pharmaceutical companies is driving the DNA methylation detection technology market.
Asia Pacific is anticipated to grow at the fastest pace in the global DNA methylation detection technology market during the forecast period. An increasing number of startups in the biotechnology and pharmaceutical industries, along with the growing application of DNA methylation detection technology as epigenetic biomarkers, are propelling the market growth.
Europe is anticipated to hold a significant share of the DNA methylation detection technology market during the projected timeframe. An increasing incidence of chronic diseases like cancer, neurological disorders, and metabolic diseases, driving the need for sophisticated diagnostic & therapeutic treatments, is driving the market.
Major vendors in the global DNA methylation detection technology market are New England Biolabs, Abcam plc., F. Hoffmann-La Roche Ltd., Thermo-Fisher Scientific Inc., Agilent Technologies Inc., BioRad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V., Illumina Inc., Pacific Biosciences Inc., Merck KGaA, PerkinElmer Inc., Enzo Life Sciences, Inc., Takara Bio Inc., Hologic, Inc., and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In February 2024, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, announced the launch of the Vericheck ddPCR Replication Competent Lentivirus Kit and the Vericheck ddPCR Replication Competent AAV Kit.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the DNA methylation detection technology market based on the below-mentioned segments:
Global DNA Methylation Detection Technology Market, By Technology
- Polymerase Chain Reaction (PCR)
- Microarray
- Sequencing
- Others
Global DNA Methylation Detection Technology Market, By Application
- Translational Research
- Diagnostic Procedure
Global DNA Methylation Detection Technology Market, By End User
- Contract Research Organization (CRO)
- Research & Academic Laboratories
- Biopharmaceutical & Biotech Companies
- Other End User
Global DNA Methylation Detection Technology Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?